Proteomics approaches to urologic diseases.
Expert Rev Proteomics
; 3(3): 283-96, 2006 Jun.
Article
en En
| MEDLINE
| ID: mdl-16771701
ABSTRACT
Biomarkers are greatly needed for several urologic diseases, such as interstitial cystitis, the symptomatic and clinical progression of benign prostate hyperplasia, as well as the specific detection of urologic cancers, including prostate and bladder cancer. This review aims to briefly describe the need for biomarkers in the field and biomarkers that are currently available for clinicians; address the limitations and roadblocks to effective biomarker discovery; and provide examples and strategies for implementing biomarkers in clinical practice and/or drug discovery.
Buscar en Google
Banco de datos:
MEDLINE
Asunto principal:
Enfermedades Urológicas
/
Proteómica
Límite:
Humans
Idioma:
En
Revista:
Expert Rev Proteomics
Asunto de la revista:
BIOQUIMICA
Año:
2006
Tipo del documento:
Article
País de afiliación:
Estados Unidos